Corcept Therapeutics (NasdaqCM:CORT) Q4 2025 Earnings call February 24, 2026 05:00 PM ET Company ParticipantsAtabak Mokari - CFOBill Guyer - Chief Development OfficerCharlie Robb - Chief Business OfficerJing He - Equity Research AssociateJoe Belanoff - CEORoberto Vieira - President of OncologySean Maduck - President of EndocrinologyConference Call ParticipantsDavid Amsellem - Managing Director and Senior Research AnalystSwayampakula Ramakanth - Managing Director and Senior Healthcare Equity Research Analyst ...